U
Minerva Surgical, Inc. UTRS
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
E
Sell 12/24/2024Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to E+ from D- on 12/24/2024 due to a noticeable decline in the volatility index.
D
Sell 12/9/2024Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to D- from E+ on 12/9/2024 due to a noticeable increase in the volatility index.
E
Sell 11/22/2024Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to E+ from D- on 11/22/2024 due to a noticeable decline in the volatility index.
D
Sell 11/7/2024Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to D- from E+ on 11/7/2024 due to a noticeable increase in the volatility index.
E
Sell 6/21/2024Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to E+ from E on 6/21/2024 due to an increase in the volatility index.
E
Sell 6/6/2024Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to E from E+ on 6/6/2024 due to a decline in the volatility index.
E
Sell 5/20/2024Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to E+ from E on 5/20/2024 due to a substantial increase in the valuation index and volatility index.
E
Sell 5/3/2024Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to E from E+ on 5/3/2024 due to a decline in the volatility index, total return index and growth index.
E
Sell 2/6/2024Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to E+ from E on 2/6/2024 due to an increase in the volatility index.
E
Sell 1/22/2024Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to E from E+ on 1/22/2024 due to a decline in the solvency index and volatility index. The quick ratio declined from 1.31 to 0.88, and debt to equity increased from 1.51 to 1.98.
E
Sell 11/18/2022Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to E+ from D- on 11/18/2022 due to a substantial decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.1966 to -$0.396, debt to equity increased from 1.3 to 1.85, and operating cash flow declined 23.8% from -$5.5M to -$6.8M.
D
Sell 11/16/2022Downgrade
Minerva Surgical, Inc. (UTRS) was downgraded to D- from D on 11/16/2022 due to a decline in the volatility index and total return index.
D
Sell 11/1/2022Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to D from D- on 11/1/2022 due to a large increase in the growth index and solvency index. Earnings per share increased from -$0.3836 to -$0.1966, operating cash flow increased 27.93% from -$7.63M to -$5.5M, and total revenue increased 18.58% from $10.94M to $12.97M.
D
Sell 7/1/2022Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to D- from E on 7/1/2022 due to an increase in the solvency index and volatility index.
E
Sell 4/1/2022Upgraded
Minerva Surgical, Inc. (UTRS) was upgraded to E from E- on 4/1/2022 due to a significant increase in the solvency index and growth index. The quick ratio increased from 0.19 to 2.1, earnings per share increased from -$1.1525 to $0.5001, and total revenue increased 9.11% from $12.51M to $13.65M.
E
Sell 1/18/2022None
Minerva Surgical, Inc. (UTRS) was downgraded to E- from U on 01/18/2022.
Weiss Ratings